David S. Geller
Section of Nephrology
Howard Hughes Medical Institute
Yale University School of Medicine
New Haven
USA
Name/email consistency: high
- A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. Geller, D.S., Zhang, J., Wisgerhof, M.V., Shackleton, C., Kashgarian, M., Lifton, R.P. J. Clin. Endocrinol. Metab. (2008)
- Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults. Geller, D.S., Zhang, J., Zennaro, M.C., Vallo-Boado, A., Rodriguez-Soriano, J., Furu, L., Haws, R., Metzger, D., Botelho, B., Karaviti, L., Haqq, A.M., Corey, H., Janssens, S., Corvol, P., Lifton, R.P. J. Am. Soc. Nephrol. (2006)
- Mineralocorticoid resistance. Geller, D.S. Clin. Endocrinol. (Oxf) (2005)
- A mineralocorticoid receptor mutation causing human hypertension. Geller, D.S. Curr. Opin. Nephrol. Hypertens. (2001)